Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhye Ahn, M.D.

Concepts (141)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Lymphocytic, Chronic, B-Cell35202416466.430 Why?
Adenine1820249942.870 Why?
Piperidines18202416642.360 Why?
Pyrazoles12202120332.070 Why?
Pyrimidines13202330471.650 Why?
Protein Kinase Inhibitors14202356961.010 Why?
Vidarabine220243430.970 Why?
Antineoplastic Agents122024136480.900 Why?
Tumor Suppressor Protein p533202129420.780 Why?
Lymphoma, B-Cell220229430.620 Why?
Pneumocystis carinii12016700.510 Why?
Pneumonia, Pneumocystis120162390.470 Why?
Antineoplastic Combined Chemotherapy Protocols72023118680.460 Why?
Antibodies, Bispecific320232030.450 Why?
Philadelphia Chromosome120131190.420 Why?
Safety1201711570.410 Why?
Drug Resistance, Neoplasm6202453370.400 Why?
Irritable Bowel Syndrome120174540.390 Why?
Herpes Zoster Vaccine22022500.360 Why?
Integrin alpha4beta1220231190.360 Why?
Multiple Myeloma3201651970.320 Why?
Warfarin1201714940.320 Why?
Cyclophosphamide2202422280.290 Why?
Apoptosis1202495140.290 Why?
Myeloproliferative Disorders120136160.280 Why?
Benzamides3202113770.270 Why?
Pyrazines3202112040.270 Why?
Phospholipase C gamma220171300.270 Why?
Follow-Up Studies72024391930.230 Why?
Lymphoma2202318970.220 Why?
Renal Insufficiency, Chronic1201723100.210 Why?
Tumor Microenvironment2202339460.210 Why?
Disease-Free Survival3202068320.210 Why?
Aged, 80 and over102021594890.200 Why?
Humans4320247659680.190 Why?
Aged1820211711170.190 Why?
Vaccines, Synthetic220226210.190 Why?
Treatment Outcome102024651880.190 Why?
Molecular Targeted Therapy2202428220.180 Why?
Proto-Oncogene Proteins c-bcl-22202414100.170 Why?
Leukemia, Hairy Cell12020820.170 Why?
Hepatitis B Vaccines120211780.160 Why?
Hypertension1201986260.160 Why?
Herpes Zoster120222520.160 Why?
Lymphoma, Follicular120234590.160 Why?
Antigens, CD19220214430.160 Why?
Atrial Fibrillation1201751890.160 Why?
Smith-Magenis Syndrome12017190.150 Why?
Immunotherapy3202347520.140 Why?
Cell Transformation, Neoplastic2201828440.140 Why?
Protein-Tyrosine Kinases2201724230.140 Why?
Prognosis52023299220.140 Why?
Chromosomes, Human, Pair 17120174160.130 Why?
Disease Progression32020136320.130 Why?
Male1820213636980.130 Why?
Immunity1202110020.120 Why?
Sulfonamides1202419840.110 Why?
Mutation42023301980.110 Why?
Middle Aged1420212230090.110 Why?
Chromosome Deletion1201713850.100 Why?
Neoplasm, Residual1201810090.100 Why?
Switzerland220233220.100 Why?
Survival Rate32021127950.100 Why?
Hydroxyurea120132840.100 Why?
Thrombocythemia, Essential120131140.100 Why?
Antiviral Agents2202130500.100 Why?
Polycythemia Vera120131600.100 Why?
Female1420213961120.090 Why?
Transplantation, Autologous1201621200.090 Why?
Salvage Therapy1201812720.090 Why?
Histone-Lysine N-Methyltransferase120166910.090 Why?
Survival Analysis22020100700.090 Why?
Kaplan-Meier Estimate2201864990.090 Why?
Hodgkin Disease1201813830.090 Why?
Adult920212230440.090 Why?
Neoplasm Proteins1202035960.070 Why?
Congresses as Topic220238110.070 Why?
Receptors, Antigen, B-Cell220235450.070 Why?
Bone Marrow1201829210.070 Why?
CD8-Positive T-Lymphocytes1202146420.070 Why?
Quinazolines1201313640.070 Why?
Anemia1201615110.070 Why?
Clinical Trials as Topic1202180410.060 Why?
Repressor Proteins1201629680.060 Why?
Evidence-Based Medicine1201636850.060 Why?
High-Throughput Nucleotide Sequencing1201736550.060 Why?
Autoimmune Diseases1201622260.060 Why?
Neoplasm Staging12018112060.050 Why?
Comorbidity12017105630.050 Why?
Coronavirus Infections1202031000.050 Why?
Pneumonia, Viral1202032230.050 Why?
Cladribine12020340.040 Why?
Enzyme Induction120204560.040 Why?
Thrombosis1201329490.040 Why?
Hematopoietic Stem Cell Transplantation1201657530.040 Why?
Immunization, Passive120206160.040 Why?
Signal Transduction12021236010.040 Why?
Incidence12016214800.040 Why?
RNA, Neoplasm120207450.040 Why?
Single-Chain Antibodies120181140.040 Why?
Lymphocytosis120181200.030 Why?
Leukocytes, Mononuclear1202318570.030 Why?
Hematologic Diseases120205000.030 Why?
Immunity, Humoral120206050.030 Why?
Adjuvants, Immunologic120219950.030 Why?
Animals320231687640.030 Why?
Mice, Inbred NOD1201818370.030 Why?
Mice, SCID1201826300.030 Why?
Immunoglobulin M1201815280.030 Why?
Drug Administration Schedule1202048500.020 Why?
Headache1202012590.020 Why?
Drug Therapy, Combination1202163090.020 Why?
Cell Adhesion1201830890.020 Why?
Anti-Inflammatory Agents1202018080.020 Why?
Disease Management1202125350.020 Why?
Tumor Cells, Cultured1201861130.020 Why?
Retrospective Studies22021815140.020 Why?
In Situ Hybridization, Fluorescence1201625050.020 Why?
Xenograft Model Antitumor Assays1201836080.020 Why?
Vaccination1202134260.020 Why?
Phosphatidylinositol 3-Kinases1201828780.020 Why?
Epigenesis, Genetic1202138190.020 Why?
Polymerase Chain Reaction1201760690.020 Why?
Antibodies, Monoclonal1202392490.020 Why?
Biopsy1201867630.020 Why?
Lymph Nodes1201834540.020 Why?
Cells, Cultured12021189730.020 Why?
RNA, Messenger12020127680.020 Why?
Neoplasm Recurrence, Local1202393730.020 Why?
Pain1202050770.020 Why?
Multivariate Analysis12018120560.010 Why?
T-Lymphocytes12021102610.010 Why?
Mice22023818190.010 Why?
Combined Modality Therapy1201685290.010 Why?
DNA1201772020.010 Why?
Proportional Hazards Models12018125090.010 Why?
Sensitivity and Specificity12017146520.010 Why?
Pandemics1202087030.010 Why?
Gene Expression Profiling1201695250.010 Why?
United States12021729030.010 Why?
Young Adult12016598890.000 Why?
Ahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.